[1]
|
Independent UK Panel on Breast Cancer Screening (2012) The Benefits and Harms of Breast Cancer Screening: An Independent Review. Lancet, 380, 1778-1786. https://doi.org/10.1016/S0140-6736(12)61611-0
|
[2]
|
Swan, J., Breen, N., Coates, R.J., et al. (2003) Progress in Cancer Screening Practices in the United States: Results from the 2000 National Health Interview Survey. Cancer, 97, 1528-1540. https://doi.org/10.1002/cncr.11208
|
[3]
|
Tabar, L., Yen, M.F., Vitak, B., et al. (2003) Mammography Service Screening and Mortality in Breast Cancer Patients: 20-Year Follow-Up before and after Introduction of Screening. Lancet, 361, 1405-1410.
https://doi.org/10.1016/S0140-6736(03)13143-1
|
[4]
|
Leung, W.K., Wu, M.S., Kakugawa, Y., et al. (2008) Screening for Gastric Cancer in Asia: Current Evidence and Practice. The Lancet Oncology, 9, 279-287. https://doi.org/10.1016/S1470-2045(08)70072-X
|
[5]
|
Ahn, H.S., Kim, H.J. and Welch, H.G. (2014) Korea’s Thyroid-Cancer “Epidemic”—Screening and Overdiagnosis. The New England Journal of Medicine, 371, 1765-1767. https://doi.org/10.1056/NEJMp1409841
|
[6]
|
Peto, J., Gilham, C., Fletcher, O., et al. (2004) The Cervical Cancer Epidemic that Screening Has Prevented in the UK. Lancet, 364, 249-256. https://doi.org/10.1016/S0140-6736(04)16674-9
|
[7]
|
Tashiro, A., Sano, M., Kinameri, K., et al. (2006) Comparing Mass Screening Techniques for Gastric Cancer in Japan. World Journal of Gastroenterology, 12, 4873-4874.
|
[8]
|
Ronco, G., Giorgi-Rossi, P., Carozzi, F., et al. (2010) Efficacy of Human Papillomavirus Testing for the Detection of Invasive Cervical Cancers and Cervical Intraepithelial Neoplasia: A Randomised Controlled Trial. The Lancet Oncology, 11, 249-257. https://doi.org/10.1016/S1470-2045(09)70360-2
|
[9]
|
Pourasad-Shahrak, S., Salehi-Pourmehr, H., Mostafa-Garebaghi, P., et al. (2015) Comparing the Results of Pap Smear and Direct Visual In-spection (DVI) with 5% Acetic Acid in Cervical Cancer Screening. Nigerian Medical Journal, 56, 35-38. https://doi.org/10.4103/0300-1652.149168
|
[10]
|
Gakidou, E., Nordhagen, S. and Obermeyer, Z. (2008) Coverage of Cervical Cancer Screening in 57 Countries: Low Average Levels and Large Inequalities. PLOS Medicine, 5, e132. https://doi.org/10.1371/journal.pmed.0050132
|
[11]
|
Katapodi, M.C., Lee, K.A., Facione, N.C., et al. (2004) Pre-dictors of Perceived Breast Cancer Risk and the Relation between Perceived Risk and Breast Cancer Screening: A Me-ta-Analytic Review. Preventive Medicine, 38, 388-402.
https://doi.org/10.1016/j.ypmed.2003.11.012
|
[12]
|
Curry, S.J., Krist, A.H., Owens, D.K., et al. (2018) Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement. JAMA, 320, 674-686. https://doi.org/10.1001/jama.2018.10897
|
[13]
|
Bibbins-Domingo, K., Grossman, D.C., Curry, S.J., et al. (2017) Screening for Gynecologic Conditions with Pelvic Examination: US Preventive Services Task Force Recommendation Statement. JAMA, 317, 947-953.
https://doi.org/10.1001/jama.2017.0807
|
[14]
|
Sherris, J., Wittet, S., Kleine, A., et al. (2009) Evidence-Based, Al-ternative Cervical Cancer Screening Approaches in Low-Resource Settings. International Perspectives on Sexual and Reproductive Health, 35, 147-154.
https://doi.org/10.1363/3514709
|
[15]
|
Siu, A.L., US Preventive Services Task Force (2009) Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine, 151, 716-726.
|
[16]
|
Voogd, A.C. (2013) The Impact of Mammography Screening on Breast Cancer Incidence. Journal of Comparative Effectiveness Research, 2, 113-116. https://doi.org/10.2217/cer.13.3
|
[17]
|
Chiarelli, A.M., Majpruz, V., Brown, P., et al. (2009) The Contribution of Clinical Breast Examination to the Accuracy of Breast Screening. JNCI: Journal of the National Cancer Institute, 101, 1236-1243.
https://doi.org/10.1093/jnci/djp241
|
[18]
|
Andresen, E.M., Peterson-Besse, J.J., Krahn, G.L., et al. (2013) Pap, Mammography, and Clinical Breast Examination Screening among Women with Disabilities: A Systematic Review. Women’s Health Issues, 23, e205-e214.
https://doi.org/10.1016/j.whi.2013.04.002
|
[19]
|
Tonelli, M., Connor, G.S., Joffres, M., et al. (2011) Recommen-dations on Screening for Breast Cancer in Average-Risk Women Aged 40 - 74 Years. CMAJ, 183, 1991-2001. https://doi.org/10.1503/cmaj.110334
|
[20]
|
Sankaranarayanan, R., Sauvaget, C., Ramadas, K., et al. (2011) Clinical Trials of Cancer Screening in the Developing World and Their Impact on Cancer Healthcare. Annals of Oncology, 22, i20-i28.
https://doi.org/10.1093/annonc/mdr422
|
[21]
|
Walsh, J.M. and Terdiman, J.P. (2003) Colorectal Cancer Screening: Scientific Review. JAMA, 289, 1288-1296.
https://doi.org/10.1001/jama.289.10.1288
|
[22]
|
Brenner, H. and Chen, H. (2017) Fecal Occult Blood versus DNA Testing: Indirect Comparison in a Colorectal Cancer Screening Population. Clinical Epidemiology, 9, 377-384. https://doi.org/10.2147/CLEP.S136565
|
[23]
|
Hol, L., van Leerdam, M.E., van Ballegooijen, M., et al. (2010) Screening for Colorectal Cancer: Randomised Trial Comparing Guaiac-Based and Immunochemical Faecal Occult Blood Testing and Flexible Sigmoidoscopy. Gut, 59, 62-68. https://doi.org/10.1136/gut.2009.177089
|